This site is intended for healthcare professionals

Chloramphenicol eye drops containing borax or boric acid in children under 2 years: MHRA update

Posted 17 Nov 2021

Dr Anish Kotecha MRCGP FAcadMEd MBBCh BSc

Dr Anish Kotecha summarises the MHRA’s recent drug safety update, offering reassurance for continued use of these eye drops in children aged 0–2 years, based on the risk–benefit profile.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page